Amphenol stock jumps 4% after JPMorgan lifts target ahead of Q4 earnings
27 January 2026
1 min read

Amphenol stock jumps 4% after JPMorgan lifts target ahead of Q4 earnings

New York, January 27, 2026, 13:19 EST — Regular session

  • Shares of Amphenol climbed 4.1%, reaching $161.96 in early afternoon trading
  • JPMorgan raised its price target to $185 from $160, maintaining its Overweight rating
  • Amphenol’s Q4 results, due Wednesday, are drawing investor attention

Shares of Amphenol Corp jumped roughly 4% Tuesday following a price target boost from JPMorgan ahead of the company’s quarterly earnings. The stock hit an intraday peak above $163 on the move.

Amphenol’s upcoming fourth-quarter results, due Wednesday, are drawing attention as investors seek updated figures on demand from cloud data centers and other electronics sectors. The company’s investor calendar lists its earnings call for Jan. 28 at 1 p.m. ET. 1

JPMorgan boosted its price target on Amphenol to $185 from $160, maintaining an Overweight rating. This move could influence near-term sentiment, even if it’s not a direct trading signal. The bank highlighted the recent CCS acquisition, saying it expands Amphenol’s reach within the optical “total addressable market”—a term analysts use for potential demand—and taps into IT and datacom spending by hyperscalers, the largest cloud operators. 2

On Jan. 12, Amphenol announced it has finalized the acquisition of CommScope’s Connectivity and Cable Solutions business, boosting its Communications Solutions segment with fiber-optic and industrial interconnect products. CEO R. Adam Norwitt highlighted that the CCS deal “adds significant fiber optic interconnect capabilities” tailored for IT datacom and communications networks. The company projects the CCS unit will bring in roughly $4.1 billion in sales by 2026 and expects it to contribute about $0.15 per share to 2026 diluted EPS, excluding costs tied to the acquisition. 3

Amphenol’s earnings expectations aren’t modest. Back in October, the company projected Q4 sales between $6.0 billion and $6.1 billion, with adjusted diluted EPS in the $0.89 to $0.91 range—figures signaling robust year-over-year growth. 4

Tuesday’s jump built on Monday’s rally. Amphenol ended Monday at $155.56, roughly 3% higher, edging near a recent peak before pushing even higher on Tuesday. 5

That setup works both ways. Should margins fall short or if management signals caution on 2026 orders following a major acquisition, traders could pull back fast from any pre-earnings rally — particularly in a stock that’s already seen a steep repricing.

Investors will be zeroed in on one thing Wednesday: if Amphenol hits its fourth-quarter targets and offers a clearer picture of growth and profit for 2026 now that CCS is part of the mix.

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Lumen Technologies (LUMN) stock jumps on ISO 42001 AI certification as earnings loom
Previous Story

Lumen Technologies (LUMN) stock jumps on ISO 42001 AI certification as earnings loom

Hecla Mining (HL) stock price slides as Casa Berardi sale and 2026 guidance sink in
Next Story

Hecla Mining (HL) stock price slides as Casa Berardi sale and 2026 guidance sink in

Go toTop